You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API CROMOLYN SODIUM


✉ Email this page to a colleague

« Back to Dashboard


Excipients in ANDA-approved (generic) drugs containing CROMOLYN SODIUM

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA Inc cromolyn sodium 0172-6406 WATER
Akorn cromolyn sodium 17478-291 BENZALKONIUM CHLORIDE
Akorn cromolyn sodium 17478-291 EDETATE DISODIUM
Akorn cromolyn sodium 17478-291 WATER
Cardinal Health cromolyn sodium 37205-223 BENZALKONIUM CHLORIDE
Cardinal Health cromolyn sodium 37205-223 EDETATE DISODIUM
Cardinal Health cromolyn sodium 37205-223 WATER
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for CROMOLYN SODIUM

Excipient focus: BENZALKONIUM CHLORIDE

CROMOLYN SODIUM drug variants not containing BENZALKONIUM CHLORIDE

Company Ingredient NDC
Meda Pharmaceuticals cromolyn sodium 0037-0678
Teva Pharmaceuticals USA Inc cromolyn sodium 0172-6406
Micro Labs Limited cromolyn sodium 42571-132
Micro Labs Limited cromolyn sodium 42571-350
Fera Pharmaceuticals LLC cromolyn sodium 48102-033
Wallace Pharmaceuticals Inc cromolyn sodium 51525-0470
Holopack Verpackungstechnik GmbH cromolyn sodium 60940-032
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: EDETATE DISODIUM

CROMOLYN SODIUM drug variants not containing EDETATE DISODIUM

Company Ingredient NDC
Meda Pharmaceuticals cromolyn sodium 0037-0678
Teva Pharmaceuticals USA Inc cromolyn sodium 0172-6406
Micro Labs Limited cromolyn sodium 42571-132
Micro Labs Limited cromolyn sodium 42571-350
Fera Pharmaceuticals LLC cromolyn sodium 48102-033
Wallace Pharmaceuticals Inc cromolyn sodium 51525-0470
Holopack Verpackungstechnik GmbH cromolyn sodium 60940-032
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: HYDROCHLORIC ACID

Excipient focus: SODIUM HYDROXIDE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group